PLANO, Texas, May 22, 2013 /PRNewswire/ -- Assured Pharmacy, Inc. (APHY), a leading pharmacy group that specializes in providing prescription medications to sufferers of chronic pain, announced it has engaged Hayden IR, a fifteen-year old, highly recognized, national investor relations firm, to raise its visibility and strengthen its relationships with the investment community.
"Over the past year, we have proven our business model and derived a plan for growth. We recently announced plans to open two additional new pharmacies in Denver and Boston as part of our major expansion strategy. These are important steps as we begin to enter the growth phase for our network of pharmacies focused on the needs of chronic pain patients and the serving physicians," said Robert DelVecchio , the Company's Chief Executive Officer. Mr. DelVecchio continued to say, "we believe it is an appropriate time to retain a national investor relations firm to help us target and expand our investor audience and ensure we are communicating effectively with Wall Street. We look forward to working with the team of professionals at Hayden IR to execute this important goal."
With offices in New York, Phoenix, Minneapolis and San Diego, Hayden IR provides a comprehensive range of investor relations services to a growing list of clients. For more than a decade, Hayden IR has been a recognized leader in driving market recognition and creating sustainable competitive advantages for more than 100 micro- and small-cap companies. Hayden delivers expertise and professionalism in such areas as investor management, relationship building, awareness campaigns, online presence and corporate identity.
Stephen Hart , VP of Capital Markets Advisory, of Hayden IR, added, "Assured Pharmacy represents a compelling opportunity as it has demonstrated landmark success at its Kansas pharmacy over the past 18 months since its opening in late-2011. The Company has a solid foundation of which to replicate as it looks to grow its pharmacy network. The Company generated $14 million of revenue in 2012 and is now embarking on a growth strategy."
Mr. Hart continued to say, "The Company's strategy is to expand to new cities in a very prudent method. Assured Pharmacy evaluates physician demand in targeted expansion cities before it commits. This strategy for growth limits the downside risk of entering a new city or geographic area. Assured Pharmacy believes it has identified and validated new locations for it to be able to double its revenue over the next two years. The team at Hayden IR looks forward to articulating this opportunity to the professional investment community."
About Assured Pharmacy, Inc.
Assured Pharmacy, Inc. is a growing provider of pharmacy services to patients and physicians in the treatment of chronic pain. Through its network of pharmacies, the Company predominantly dispenses highly regulated pain medications to sufferers of chronic pain, while stringently adhering to federal and state reporting requirements for both patients and physicians. The majority of the Company's business is derived from repeat visits from its customer base of physician-referred chronic pain patients. The Company currently has four operating pharmacies which are wholly owned. Learn more about Assured Pharmacy, Inc. at www.AssuredRxServices.com
Forward-Looking Statements. This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act") (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words "believe," "anticipate," "estimate," "expect," "intend," "plan," "project," "prospects," "outlook," and similar words or expressions, or future or conditional verbs such as "will," "should," "would," "may," and "could" are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company's forward-looking statements, please see the Company's Annual Report on Form 10-K for the year ended December 31, 2011, including but not limited to the discussion under "Risk Factors" therein, which the Company has filed with the SEC and which may be viewed at http://www.sec.gov.
Robert DelVecchio , CEO
|SOURCE Assured Pharmacy, Inc.|
Copyright©2012 PR Newswire.
All rights reserved